Literature DB >> 1328077

Prevalence and cytologic manifestations of human papilloma virus (HPV) types 6, 11, 16, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52, and 56 among 500 consecutive women.

N B Kiviat1, L A Koutsky, C W Critchlow, A T Lorincz, A P Cullen, J Brockway, K K Holmes.   

Abstract

The prevalence and associated cytologic manifestations of cervical infection with human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52, and 56 were studied among 500 consecutive women attending the Harborview Medical Center Sexually Transmitted Diseases (STD) Clinic in Seattle, WA. Using radiolabeled-probes without prior amplification of DNA, HPV DNA was detected in cervical specimens from 120 (24%) of the women and was found to be more prevalent than Chlamydia trachomatis (13%), Neisseria gonorrhoeae (12%), or mucopurulent cervicitis (20%). High-risk HPV types 16 or 18 were present alone in 5% of the women; intermediate-risk types 31, 33, 35, 45, 51, 52, or 56 in 3%; and low-risk types 6, 11, 42, 43, and 44 in 5%. In an additional 8% HPV DNA was detected but could be characterized only as being type 6, 11, 16, 18, 31, 33, or 35. Each grouping of HPV types was equally associated with squamous intraepithelial lesions (SILs) of the cervix. In the absence of SIL and koilocytosis, the cytologic changes associated with HPV infection included frequent binucleation and variation in nuclear size and chromatin distribution. Parakeratosis and hyperkeratosis without nuclear atypia were not associated with HPV DNA. The natural history and clinical significance of these HPV-associated lesions remain to be defined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328077     DOI: 10.1097/00004347-199207000-00005

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  6 in total

Review 1.  Pathogenesis of genital HPV infection.

Authors:  A Schneider
Journal:  Genitourin Med       Date:  1993-06

2.  Influence of age and human papillomavirus-infection on reliability of cervical cytopathology.

Authors:  C Kainz; C Tempfer; G Gitsch; H Heinzl; A Reinthaller; G Breitenecker
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

3.  Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study.

Authors:  G J Van Doornum; M Prins; L H Juffermans; C Hooykaas; J A van den Hoek; R A Coutinho; W G Quint
Journal:  Genitourin Med       Date:  1994-08

4.  Polymerase chain reaction-assisted papillomavirus detection in cervicovaginal smears: stratification by clinical risk and cytology reports.

Authors:  C Kühler-Obbarius; K Milde-Langosch; G Helling-Giese; A Salfelder; C Peimann; T Löning
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay.

Authors:  Patricia Rantshabeng; Ishmael Kasvosve; Andrew Ndlovu; Simani Gaseitsiwe; Sikhulile Moyo
Journal:  PLoS One       Date:  2019-01-30       Impact factor: 3.240

6.  HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3.

Authors:  J K Chan; B J Monk; C Brewer; K A Keefe; K Osann; S McMeekin; G S Rose; M Youssef; S P Wilczynski; F L Meyskens; M L Berman
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.